Antidiabetic and hyperglycemic amines

Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib can activate lysosomal adenosine monophosphate-activated protein kinase (AMPK) and decreases blood glucose. Aldometanib can be used for the research of metabolic

Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib can activate lysosomal adenosine monophosphate-activated protein kinase (AMPK) and decreases blood glucose. Aldometanib can be used for the research of metabolic

Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib can activate lysosomal adenosine monophosphate-activated protein kinase (AMPK) and decreases blood glucose. Aldometanib can be used for the research of metabolic

AR453588 is a potent and orally bioavailable anti-diabetic glucokinase activator, with an EC 50 of 42 nM. AR453588 shows anti-hyperglycemic activity.In VivoAR453588 (3-30 mg/kg: p.o) lowers post-prandial glucose in normal C57BL/6J mice . AR453588

AR453588 is a potent and orally bioavailable anti-diabetic glucokinase activator, with an EC 50 of 42 nM. AR453588 shows anti-hyperglycemic activity.In VivoAR453588 (3-30 mg/kg: p.o) lowers post-prandial glucose in normal C57BL/6J mice . AR453588

AR453588 is a potent and orally bioavailable anti-diabetic glucokinase activator, with an EC 50 of 42 nM. AR453588 shows anti-hyperglycemic activity.In VivoAR453588 (3-30 mg/kg: p.o) lowers post-prandial glucose in normal C57BL/6J mice . AR453588

AR453588 is a potent and orally bioavailable anti-diabetic glucokinase activator, with an EC 50 of 42 nM. AR453588 shows anti-hyperglycemic activity.In VivoAR453588 (3-30 mg/kg: p.o) lowers post-prandial glucose in normal C57BL/6J mice . AR453588

AR453588 is a potent and orally bioavailable anti-diabetic glucokinase activator, with an EC 50 of 42 nM. AR453588 shows anti-hyperglycemic activity.In VivoAR453588 (3-30 mg/kg: p.o) lowers post-prandial glucose in normal C57BL/6J mice . AR453588

AR453588 is a potent and orally bioavailable anti-diabetic glucokinase activator, with an EC 50 of 42 nM. AR453588 shows anti-hyperglycemic activity.In VivoAR453588 (3-30 mg/kg: p.o) lowers post-prandial glucose in normal C57BL/6J mice . AR453588

A pyrimidine compound that acts as an effective GPR119 agonist (EC 50 = 2.5 &#181M in stimulating cAMP in hGPR119-expressing HEK293 cells) and reportedly exhibits no activity toward &#946-adrenergic or GLP-1 receptors.

HOOK&trade-NHS-dPEG&trade₄-Biotin reacts with protein primary amines. Amines, lysine &epsilon-amines and N-terminal &alpha-amines, are the most abundant group in protein molecules and represent the most common target for biotinylation.

Maleimide PEG amine (Maleimide-PEG-NH2) is a thiol reactive heterobifunctional PEG derivative. Maleimide groups react with sulfhydryl groups at pH 6.5~7.5 at room temperature to form stable thioether bonds, while primary amine groups on the other